Filing metadata

Accession number
0001127602-23-017568
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Jun 02, 2023
Reporting period
Jun 01, 2023
Description
Insider transaction

Explore SEC Filings Hub